Skip to content

Total Assets at other companies

Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$11.86B+2.8%
Axsome Therapeutics logo
Axsome TherapeuticsAXSM
$713.61M+19.6%
Biogen logo
BiogenBIIB
$29.48B+5.2%
Alkermes logo
AlkermesALKS
$4.26B+105%
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
$4.91B+33.0%
TG Therapeutics logo
TG TherapeuticsTGTX
$1.53B+133%

Other financials

Income statement

See full
Revenue--100%
Operating income-$105.9M-41.7%
Net income-$92.6M-33.6%
EPS (diluted)-$3.20+2.7%

Balance sheet

See full
Cash & equivalents$536.7M+223%
Total debt$1.4M+31.3%
Total equity$1.4B+221%

Cash flow

See full
Operating cash flow-$86.2M-62.5%
CapEx$62.0K
Free cash flow-$86.2M-62.6%

Valuation

See full
Market cap$7.87B+1,075%
Enterprise value$7.34B+1,309%

Profitability

See full
Operating margin-3,927.5%-1,497pp
Net margin-3,658.5%-1,388pp
FCF margin-3,067.4%-1,030pp

Returns & leverage

See full
Return on equity-35.3%-10.9pp
Debt / equity0.0×
Current ratio15.9×+7.4×

Where this comes from

Reported directly by Praxis Precision Medicines, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Praxis Precision Medicines, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Praxis Precision Medicines, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Praxis Precision Medicines, Inc.'s total assets?
Praxis Precision Medicines, Inc. (PRAX) reported total assets of $1.46B in Q1 2026.
How has Praxis Precision Medicines, Inc.'s total assets changed year-over-year?
Praxis Precision Medicines, Inc.'s total assets increased by 205.0% year-over-year, from $478.74M to $1.46B.
What is the long-term trend for Praxis Precision Medicines, Inc.'s total assets?
Over 5 years (2020 to 2025), Praxis Precision Medicines, Inc.'s total assets has grown at a 25.3% compound annual growth rate (CAGR), from $303.18M to $937.91M.
What does total assets mean?
The total value of everything the company owns.
How do you interpret total assets?
Growth in total assets generally signals company expansion, whereas a decline may indicate asset liquidation or significant operational downsizing.
How does total assets compare across companies?
Total assets vary widely by industry; for biotech, this is heavily influenced by cash reserves and capitalized R&D infrastructure.